Accueil>>Signaling Pathways>> Proteases>> HSP>>3-Phenyltoxoflavin

3-Phenyltoxoflavin

Catalog No.GC61582

La 3-phényltoxoflavine, un dérivé de la toxoflavine, est un inhibiteur de Hsp90, avec un Kd de 585 nM pour l'interaction Hsp90-TPR2A. La 3-phényltoxoflavine a une activité anticancéreuse.

Products are for research use only. Not for human use. We do not sell to patients.

3-Phenyltoxoflavin Chemical Structure

Cas No.: 32502-63-9

Taille Prix Stock Qté
10mM (in 1mL DMSO)
306,00 $US
En stock
5 mg
278,00 $US
En stock
10 mg
464,00 $US
En stock
25 mg
908,00 $US
En stock
50 mg
1 437,00 $US
En stock
100 mg
2 178,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

3-Phenyltoxoflavin, a derivative of Toxoflavin, is an Hsp90 inhibitor, with a Kd of 585 nM for the interaction of Hsp90-TPR2A. 3-Phenyltoxoflavin has anti-cancer activity[1][2].

3-Phenyltoxoflavin (1 nM-100 μM; 4 d) inhibits BT474 cells proliferation in a concentration-dependent manner, with an IC50 of 690 nM[1].3-Phenyltoxoflavin (0.56 nM-100 μM; 2 h) competes with biotinylated Hsp90 peptide for its binding to TPR2A in a dose-dependent manner[1].

[1]. Yi F, et, al. A novel class of small molecule inhibitors of Hsp90. ACS Chem Biol. 2008 Oct 17;3(10):645-54. [2]. Koh S, et, al. A novel light-dependent selection marker system in plants. Plant Biotechnol J. 2011 Apr;9(3):348-58.

Avis

Review for 3-Phenyltoxoflavin

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 3-Phenyltoxoflavin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.